Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...

A Wednesday night earnings report left big questions about how the spending reductions would affect the company.

Biotech company 10x Genomics (NASDAQ:TXG) reported Q4 CY2024 results , but sales fell by 10.3% year on year to $165 million.

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic ...

New heart health biopharmaceutical company Kardigan, which counts among its co-founders the director for Northwestern ...

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...